Filing Details
- Accession Number:
- 0001415889-24-009068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-25 19:31:07
- Reporting Period:
- 2023-03-25
- Accepted Time:
- 2024-03-25 19:31:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468308 | Robert Andrade | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2024-03-25 | 13,975 | $11.00 | 105,746 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a 10b5-1 plan adopted on August 16, 2023.
Billionaire Hedge Funds
